Bosch at Achema - New Inspection Technologies for Higher product Quality and Safety
At Achema 2015, Bosch Packaging Technology showcases two new pharmaceutical inspection machines. The KHS 1 is a new development emerging from a co-operation of Bosch with Lighthouse Instruments. It is designed for container closure integrity testing of ampoules, vials, bottles, cartridges and syringes using laser headspace analysis (HSA). The AIM 3, in turn, is the new member of the well-established AIM series. It offers the possibility to perform both visual inspection and high-voltage leak detection (HVLD) for ampoules and vials on one single platform. “These new platforms underline the expertise of Bosch Packaging Technology in all inspection areas. Independent of the product or application, we can offer extensive consulting and the appropriate technology to ensure the highest product safety and quality for all requirements,” Mahmoud Hamada, business development manager at Bosch Inspection Technology, explains.
Successful Co-operation with HSA Pioneer
To further expand its inspection portfolio, Bosch collaborated with Lighthouse Instruments, the leading provider of non-destructive laser spectroscopy headspace analysis systems. This expertise in leak detection fits ideally with the highest quality requirements of the pharmaceutical industry. “By combining this expertise with our market-leading machinery for pharmaceutical inspection applications, we have developed a highly flexible and customizable high-speed platform,” says Joachim Baczewski, head of Inspection Technology and president of Bosch Packaging Technology K.K. in Japan. Jim Veale, president of Lighthouse Instruments, adds: “We are excited to offer the pharmaceutical industry best-in-class leak detection machines together with Bosch Packaging Technology.”
The KHS 1 is the new high-end leak detection system from Bosch for closure integrity testing with laser headspace analysis. It measures the absorbed light passing through the headspace region via laser spectroscopy. HSA is applicable to lyophilized products and medicines filled under vacuum or purged with inert
gas. The new KHS 1 inspects both standing and non-standing containers at outputs of up to 600 per minute, and can combine HSA with optional near infrared (NIR) measurement and container coding. In order to ensure the highest reliability and accuracy, a built-in automatic re-calibration is continuously performed using certified reference containers.
AIM 3: Compact Platform for Visual Inspection and Leak Detection
Eisai Machinery (now Bosch Inspection Technology) developed the first model of the AIM series 40 years ago. In 1985, the successful KLD series using HVLD technology was introduced. It detects leaks by measuring the electrical resistance of containers with conductive solutions. At Achema, Bosch now launches the new AIM 3, which combines both visual inspection of the AIM series and high-voltage leak detection of the KLD series. It inspects ampoules and vials containing solutions and suspensions at outputs of up to 400 containers per minute. “Our aim was to offer pharmaceutical producers and contract manufacturers from all over the world an economical solution for medium speeds at high Bosch quality standards,” Mahmoud Hamada explains.
To sort out damaged containers before they enter the main inspection turret, the AIM 3 is equipped with a pre-inspection station. The core module features a high-resolution CMOS camera with high-speed interface for particle and cosmetic inspection, as well as a re-inspection function. The customizable platform can be retrofitted on site to add further visual inspection stations or the HVLD module. The latter delivers equivalent measurement results for all glass qualities, such as molded and tubing, as well as clear and amber glass. Both
inspection steps are controlled via one common Human Machine Interface (HMI).
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance